According to the World Health Organization (WHO), Ebola symptoms appear between two and 21 days after infection, and can include fever, severe headache, muscle pain, fatigue, abdominal pain ...

Discovered in 1976, Ebola is rare, deadly and has multiple variations. There is a vaccine for the Zaire type, now trials for another are underway.

02/06/2025February 6, 2025 Discovered in 1976, Ebola is rare, deadly and has multiple variants. There is a vaccine for the Zaire type. Now, trials for another strain are underway.

Ebola occurs when someone is infected with orthoebolavirus zairense, which is a virus mainly found in sub-Saharan Africa, according to the Centers for Disease Control and Prevention (CDC).

Ebola Zaire is the most common cause of outbreaks, followed by Ebola Sudan. But there are long stretches between outbreaks of the latter, making it difficult to test drugs or vaccines for this ...

It protects only against Zaire ebolavirus, not the other strains that can infect humans. The Ervebo vaccine does not contain the Ebola virus.

The Food and Drug Administration (FDA) has expanded the approval of Ervebo ® (Ebola Zaire vaccine, live) to include individuals 12 months of age and older for the prevention of disease caused by ...

Ebola spreads through contact with the bodily fluids of an infected person and has a fatality rate of about 50%. More than 11,300 people died during the 2013-2016 outbreak in West Africa.

A general view of a newly installed Ebola Treatment Unit, with 32 beds, also to be used as a research center for Ebola strains and vaccine trial, in Kampala, Uganda, December 9, 2022.